Leinco Technologies, Inc.'s Anti-Human EGFR (Cetuximab) - 100 mg monoclonal antibody. The Anti-Human EGFR (Cetuximab) - 100 mg Antibody was generated using EGFR, and epidermal growth factor receptor as the antigen. It reacts with Homo Sapiens, and Human. This antibody has been shown to work in applications such as: EIA, Immunoassay, Mass Cytometry, ELISA, Flow Cytometry, Functional Assay, Immunocytochemistry, and Immunohistochemistry.